The global nasal polyposis drug market is anticipated to grow at a significant CAGR during the forecast period Nasal polyps are soft, painless, noncancerous growths on the lining of nasal passages or sinuses. Nasal polyps are caused due to chronic inflammation and are related to asthma, recurring infection, allergies, drug sensitivity or certain immune disorders. The major factor accelerating the growth of the market include the rising prevalence of numerous cancers as well as immunological disorders coupled with the increasing geriatric population across the globe. Furthermore, the market is propelling due to growing chronic sinusitis globally. According to the Center for Disease Control and Prevention (CDC), in 2018, 28.9 million or 11.6% adults are diagnosed with chronic sinusitis in the US. Additionally, an estimated 2.7 million people visited physician offices and 234,000 people visited emergency departments due to the condition. Hence, the rising prevalence of the disease is driving the growth of the global nasal polyposis drug market.
To Request a Sample of our Report on Nasal Polyposis Drug Market https://www.omrglobal.com/request-sample/nasal-polyposis-drug-market
Some major players operating in the market include Sanofi S.A, Merck & Co Inc., and GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2021, GlaxoSmithKline announced the approval of Nucala (mepolizumab) from the FDA. It is used for the treatment of patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drug Class
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Sanofi S.A, Merck & Co Inc., and GlaxoSmithKline plc, among others.
A full Report of Nasal Polyposis Drug Market is Available @ https://www.omrglobal.com/industry-reports/nasal-polyposis-drug-market
Nasal Polyposis Drug Market Report by Segment
By Drug Class
- Corticosteroids
- Antibiotics
- Leukotriene Inhibitors
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Nasal Polyposis Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
